1/6/2024 0 Comments Mekhman mamedov email![]() In terms of percentage, 55.9 %o of CVD lethal cases occur in Russia, and 47 %o of them occur in Europe. In particular, more than 4 mln cases of death registered in Europe each year occur due to CVD, and 1 mln of them happen in Russia. īut cardiovascular diseases (CVD) take the leading position between the causes of lethality in the majority of countries. According to the World Health Organization (WHO) prognosis, within the next 20 %o this number will increase approximately by 70 %o. 8,8 mln people died due to cancer in 2015. Cancer is the cause of each sixth death in the world. 589 341 new cancer cases were diagnosed in 2015, and this number is 4,0 % higher comparing with the previous year (270 046 male cases and 319355 female cases). According to the information collected by Hertsen Moscow Oncology Research Center, cancer morbidity has been increasing constantly during the last few years. E-mail: cancer is the main and one of the most significant healthcare problems in Russia and in the world. Сancer, antitumoral drugs, chemotherapy, radiotherapy, cardiotoxicity, prevention. Mamedov, M.D., Ph.D., doctor of sciences, professor, head of the laboratory of interdisciplinary approach for prevention of chronic non-infectious diseases, National Research Centre for Preventive Medicine, Moscow, Russia. Saribekyan, M.D., Ph.D., doctor of sciences, leading researcher of the department of oncology and plastic and reconstructive skin and breast surgery, Hertsen Moscow Oncology Research Center - National Medical Research Radiology Center, Moscow, Russia Yandieva, M.D., research assistant of the department of prevention of comorbid diseases, National Research Centre for Preventive Medicine, Moscow, Russia Įrik K. Yandieva R.A.1*, Saribekyan E.K.3, Mamedov M.N.1ġ National Research Centre for Preventive Medicine of the Ministry of Healthcare of the Russian Federation, Moscow, Russia 2 Hertsen Moscow Oncology Research Center - National Medical Research Radiology Center of the Ministry of Healthcare of the Russian Federation, Moscow, Russia International Heart and Vascular Disease Journal Volume 5, Number 15, September 2017 Taking into account all above-mentioned points, well-timed detection, monitoring and treatment of complications arising during and after anticancer therapy become new relevant tasks in clinical practice. Many chemotherapy agents have cardiotoxic effects that often are refractory to treatment and that are mostly manifested as asymptomatic ECG changes up to myocardial infarction, as various rhythm and conduction disorders, or as toxic cardiomyopathy with signs of severe heart failure. In accordance with it, time, the number of patients suffering from various complications including cardiologic ones has increased proportionally. Life expectancy and relapse-free survival in cancer patients have increased significantly due to advanced diagnostics and innovative pharmacological treatment and radiotherapy. ![]() Nowadays cancer is the second leading cause of death in Europe and in Russia.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |